(Q43674501)

English

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

medullary carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

carcinoid tumor

1 reference

based on heuristic

inferred from title

G. Michael Besser

11

object named as

Besser GM

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Ashley Grossman

12

object named as

Grossman AB

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Mukherjee JJ

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kaltsas GA

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Islam N

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Plowman PN

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Foley R

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hikmat J

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Britton KE

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jenkins PJ

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Chew SL

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Monson JP

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

47-60

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

The role of I-131-MIBG in the diagnosis and therapy of carcinoids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Malignant phaeochromocytoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Malignant pheochromocytoma: clinical course and treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

The management of patients with advanced carcinoid tumors and islet cell carcinomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Scintigraphic Localization of Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01309.X

21 January 2018

Identifiers

10.1046/J.1365-2265.2001.01309.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43674501&oldid=2102427230"